Enteral vancomycin to control MRSA [4]

Journal of Hospital Infection

Volumn 59, Issue 3, 2005, Pages 263-266

  van Saene, H K F ^a   Weir, W I ^b   de la Cal, M A ^c   Silvestri, L ^d   Petros, A J ^e   Barrett, S P ^f  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

^c HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^d Ospedale Civile di Gorizia   (Italy)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; BETA LACTAMASE; CIPROFLOXACIN; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; POLYPEPTIDE ANTIBIOTIC AGENT; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTIFICIAL VENTILATION; BACTERIAL OVERGROWTH; BACTERIAL PNEUMONIA; BACTERIUM CONTAMINATION; BACTERIUM ISOLATE; CLINICAL TRIAL; DIGESTIVE SYSTEM; DRUG EFFICACY; ERADICATION THERAPY; EVIDENCE BASED MEDICINE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; INTESTINE FLORA; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; SEPTICEMIA; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 13344293606     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2004.11.004     Document Type: Letter

References (23)

1. F. Daschner MRSA - really time for a more pragmatic approach? J Hosp Infect 59 2005 260
2. H. Humphreys E.G. Smyth Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units J Hosp Infect 59 2005 260
3. S. Dancer No magic bullet for MRSA J Hosp Infect 59 2005 261
4. Liberati A, D'Amico R, Pifferi S, et al. Antibiotic prophylaxis to reduce respiratory tract infection and mortality in adults receiving intensive care (Cochrane Review) The Cochrane Library, Issue 1. Chichester: Wiley; 2004
5. W.A. Krueger F.P. Lenhart G. Neeser et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients Am J Respir Crit Care Med 166 2002 1029-1037
6. E. de Jonge J.M. Schultz L. Spanjaard et al. Effects of selective decontamination of the digestive tract on mortality and acquisition of resistant bacteria in intensive care: A randomized controlled trial Lancet 362 2003 1011-1016
7. W. Ebner A. Kropec-Hubner F.D. Daschner Bacterial resistance and overgrowth due to selective decontamination of the digestive tract Eur J Clin Microbiol Infect Dis 19 2000 243-247
8. M.A. de la Cal E. Cerda H.K.F. van Saene et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit J Hosp Infect 56 2004 175-183
9. L. Silvestri M. Milanese L. Oblach et al. Enteral vancomycin to control a methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients Am J Infect Control 30 2002 391-399
10. U. Stiefel D.L. Paterson N.J. Pultz et al. Effect of increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers Infect Control Hosp Epidemiol 25 2004 380-383
11. C.D. Salgado E.T. Giannetta B.M. Farr Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile Infect Control Hosp Epidemiol 25 2004 413-417
12. Sanchez M, Mir N, Canton R, et al. The effect of topical vancomycin on acquisition, carriage and infection with methicillin-resistant Staphylococcus aureus [MRSA] in critically ill patients. A double-blind, randomized, placebo-controlled study. 37th ICAAC; 1997, Abstract J-119, p. 310
13. L. Silvestri H.K.F. van Saene M. Milanese et al. Prevention of MRSA pneumonia by oral vancomycin decontamination: A randomised trial Eur Respir J 23 2004 921-926
14. R. Winter H. Humphreys A. Pick et al. A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection J Antimicrob Chemother 30 1992 73-87
15. H. Humphreys R. Winter A. Pick The effect of selective decontamination of the digestive tract on gastro-intestinal enterococcal colonization in ITU patients Intensive Care Med 18 1992 459-463
16. M. Garrouste-Orgeas O. Marie M. Rouveau et al. Secondary carriage with multi-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: Relationship with nosocomial infections and mortality J Hosp Infect 34 1996 279-289
17. F.Y. Chang N. Singh T. Gayowski et al. Staphylococcus aureus nasal colonization in patients with cirrhosis: Prospective assessment of association with infection Infect Control Hosp Epidemiol 19 1998 328-332
18. M.E. Taylor B.A. Oppenheim Selective decontamination of the gastro-intestinal tract as an infection control measure J Hosp Infect 17 1991 271-278
19. E.J.T. Luiten W.C.J. Hop H.P. Endtz H.A. Bruining Prognostic importance of Gram-negative intestinal colonization preceding pancreatic infection in severe acute pancreatitis. Results of a controlled clinical trial of selective decontamination Intensive Care Med 24 1998 438-445
20. H.K.F. van Saene V. Damjanovic B. Pizer A.J. Petros Fungal infections in ICU J Hosp Infect 41 1999 337-340
21. W.A. Krueger G. Ruckdeschel K. Unertl Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate Antimicrob Agents Chemother 41 1997 1725-1730
22. H. Lode N. van der Höh S. Ziege et al. Ecological effects of linezolid versus amoxicillin/clavulanic acid on normal intestinal flora Scand J Infect Dis 33 2001 899-903
23. W.C. Hellinger J.D. Yao S. Alvarez et al. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation Transplantation 73 2002 1904-1909